價格 | ¥339 | ¥792 | ¥1170 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 GC376 sodium | 英文名稱:GC376 sodium |
CAS:1416992-39-6 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: ≥98% | 產(chǎn)品類別: 抑制劑 |
貨號: T5188 |
名稱 | GC376 sodium |
描述 | GC376 is an inhibitor of 3C-like proteases (3CLpro) with IC50 values range from 0.49~4.35 μM. |
細胞實驗 | The toxic dose for 50% cell death (TD50) for each compound was determined for the various cells used in this study. Confluent cells grown in 96-well plates were treated with various concentrations (1 to 500 μM) of each compound for 72 h. Cell cytotoxicity was measured by a CytoTox 96 nonradioactive cytotoxicity assay kit and crystal violet staining. The in vitro therapeutic index was calculated by dividing the TD50 by the IC50 [1]. |
動物實驗 | GC376 was synthesized in a highly pure form and formulated at a concentration of 53 mg/ml in 10% ethanol and 90% polyethylene glycol 400, as described previously. GC376 was administered subcutaneously (SC) at a dosage of 15 mg/kg q12h SC, unless stated otherwise. The effective dosage for cats with experimentally induced FIP was 10 mg/kg/ q12h SC, but the dosage was raised to 15 mg/kg after the first cat (CT01) failed to respond to a lower dose of 10 mg/kg suggested by earlier pharmacokinetic studies. This was a clinical decision based on this one cat's response to treatment [2]. |
體外活性 | GC376對冠狀病毒(TGEV、FIPV、MHV、229E和BCV)、卡利西病毒(NV和MNV-1)以及皮克納病毒(HRVs 18、51和68、EV71和PTV)表現(xiàn)出顯著的抑制效果,IC50值達到納摩爾或低微摩爾水平,除了FCV和HAV外。有趣的是,F(xiàn)CV對GC376的敏感性較低,其IC50值為35 μM [1]。 |
體內(nèi)活性 | GC376以15 mg/kg的劑量,每12小時通過皮下注射給藥。結(jié)果表明,在初始治療后的2周內(nèi),20只接受GC376治療的貓中有19只恢復了正常健康狀況。然而,疾病跡象在初次治療后1-7周內(nèi)復發(fā),復發(fā)和新發(fā)病例最終需要至少治療12周。在初次或重復治療后的1-7周內(nèi),13只中的19只貓發(fā)生了不再對治療有反應的復發(fā) [2]。 |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | 5% DMSO+95% Saline : 2.25 mg/mL (4.43 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. DMSO : 45 mg/mL (88.66 mM) |
關(guān)鍵字 | GC-376 sodium | GC376 sodium |
相關(guān)產(chǎn)品 | Umifenovir hydrochloride | Imatinib | Chloroquine phosphate | Andrographolide | Dexamethasone | Hydroxychloroquine | EIDD-1931 | Silymarin | Nirmatrelvir | Ritonavir | Favipiravir | Remdesivir |
相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 抗感染化合物庫 | 抗COVID-19化合物庫 | NO PAINS 化合物庫 | 臨床前化合物庫 | 抗病毒庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術(shù)服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號
|
2025-02-26 | |
詢價 |
VIP8年
|
河南阿爾法化工有限公司
|
2025-02-26 | |
詢價 |
VIP4年
|
河南拉瓦錫化工產(chǎn)品有限公司
|
2025-02-21 | |
詢價 |
VIP1年
|
寶雞締都醫(yī)藥化工有限公司
|
2025-02-18 | |
¥720.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
詢價 |
VIP10年
|
上海與昂化工有限公司
|
2024-07-09 | |
¥89000 |
三本生物技術(shù)(蘇州)有限公司
|
2023-11-21 | ||
詢價 |
上海與昂生物科技有限公司
|
2023-10-23 | ||
詢價 |
上海蓓瑯生物科技有限公司
|
2022-08-16 | ||
詢價 |
VIP10年
|
上海與昂化工有限公司
|
2024-07-09 |